Biomolecular Life Holdings, Inc. engages in developing, marketing and selling of dietary supplements and wellness formulations for both humans and pets. Its products includes BIOREVIT and IMMUNO. The company was founded by David Contreras on July 11, 1995 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biomolecular Life Holdings Inc. market cap is $632,864.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biomolecular Life Holdings Inc. 52 week high is $2.25 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biomolecular Life Holdings Inc. 52 week low is $0.02 as of November 22, 2026.
Biomolecular Life Holdings Inc. stock price today is $0.60.
Biomolecular Life Holdings Inc. stock price yesterday was $0.99.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biomolecular Life Holdings Inc.'s P/E ratio is -1.28.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biomolecular Life Holdings Inc. P/B ratio is -7.7841.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biomolecular Life Holdings Inc. 50-day moving average is $0.6966.